BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21869879)

  • 1. PARADOXICAL RESPONSES TO NEUROTOXIC STERYL GLYCOSIDES: INSIGHTS FROM A CELLULAR MODEL OF ALSPDC.
    Shaw CA; Pelech S; Ly PT
    Neurobiol Lipids; 2009 Jan; 8(1):1-5. PubMed ID: 21869879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel environmental toxins: steryl glycosides as a potential etiological factor for age-related neurodegenerative diseases.
    Ly PT; Singh S; Shaw CA
    J Neurosci Res; 2007 Feb; 85(2):231-7. PubMed ID: 17149752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam: immunohistochemical studies.
    Hirano A
    Keio J Med; 1992 Mar; 41(1):6-9. PubMed ID: 1583817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
    Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
    J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Western Pacific ALS-PDC: Evidence implicating cycad genotoxins.
    Spencer PS; Palmer VS; Kisby GE
    J Neurol Sci; 2020 Dec; 419():117185. PubMed ID: 33190068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?
    Kisby G; Palmer V; Lasarev M; Fry R; Iordanov M; Magun E; Samson L; Spencer P
    Commun Integr Biol; 2011 Nov; 4(6):731-4. PubMed ID: 22446540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.
    Spencer PS; Palmer VS; Kisby GE
    Neurotoxicology; 2016 Sep; 56():269-283. PubMed ID: 27050202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.
    Schulz JD; Hawkes EL; Shaw CA
    Med Hypotheses; 2006; 66(6):1222-6. PubMed ID: 16488551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
    Cox PA; Banack SA; Murch SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct pathological features of the gallyas- and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Oyanagi K; Makifuchi T; Ohtoh T; Chen KM; Gajdusek DC; Chase TN
    J Neuropathol Exp Neurol; 1997 Mar; 56(3):308-16. PubMed ID: 9056545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam.
    Cox PA; Sacks OW
    Neurology; 2002 Mar; 58(6):956-9. PubMed ID: 11914415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Counseling Dilemmas for a Patient with Sporadic Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration & Parkinson's Disease.
    Mantero V; Tarlarini C; Aliprandi A; Lauria G; Rigamonti A; Abate L; Origone P; Mandich P; Penco S; Salmaggi A
    J Genet Couns; 2017 Jun; 26(3):442-446. PubMed ID: 28247171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.
    Wilson JM; Petrik MS; Moghadasian MH; Shaw CA
    Can J Physiol Pharmacol; 2005 Feb; 83(2):131-41. PubMed ID: 15791286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lessons from Guam ALS/PDC study].
    Asao H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):717-21. PubMed ID: 18210783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kampō medicine and Muro disease (Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex).
    Spencer PS; Palmer VS; Kihira T; Yoshida S; Reis J; Yabushita M; Yase Y
    eNeurologicalSci; 2020 Mar; 18():100230. PubMed ID: 32090178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are age-related neurodegenerative diseases linked with various types of magnesium depletion?
    Durlach J; Bac P; Durlach V; Durlach A; Bara M; Guiet-Bara A
    Magnes Res; 1997 Dec; 10(4):339-53. PubMed ID: 9513930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex.
    Khabazian I; Bains JS; Williams DE; Cheung J; Wilson JM; Pasqualotto BA; Pelech SL; Andersen RJ; Wang YT; Liu L; Nagai A; Kim SU; Craig UK; Shaw CA
    J Neurochem; 2002 Aug; 82(3):516-28. PubMed ID: 12153476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.